These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 11448296

  • 1. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy.
    Warmuth-Metz M, Naumann M, Csoti I, Solymosi L.
    Arch Neurol; 2001 Jul; 58(7):1076-9. PubMed ID: 11448296
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Differentiation of atypical Parkinson syndrome and delineation from idiopathic Parkinson syndrome with routine magnetic resonance tomography].
    Csoti I, Warmuth-Metz M, Solymosi L, Becker Dagger G, Fornadi F, Naumann M.
    Nervenarzt; 2004 Feb; 75(2):128-34. PubMed ID: 14770282
    [Abstract] [Full Text] [Related]

  • 7. Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging.
    Cosottini M, Ceravolo R, Faggioni L, Lazzarotti G, Michelassi MC, Bonuccelli U, Murri L, Bartolozzi C.
    Acta Neurol Scand; 2007 Jul; 116(1):37-42. PubMed ID: 17587253
    [Abstract] [Full Text] [Related]

  • 8. Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome.
    Ahn JH, Kim M, Kim JS, Youn J, Jang W, Oh E, Lee PH, Koh SB, Ahn TB, Cho JW.
    Parkinsonism Relat Disord; 2019 Sep; 66():80-86. PubMed ID: 31307918
    [Abstract] [Full Text] [Related]

  • 9. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
    Eraslan C, Acarer A, Guneyli S, Akyuz E, Aydin E, Colakoglu Z, Kitis O, Calli MC.
    Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485
    [Abstract] [Full Text] [Related]

  • 10. Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy.
    Asato R, Akiguchi I, Masunaga S, Hashimoto N.
    J Neural Transm (Vienna); 2000 Feb; 107(12):1427-36. PubMed ID: 11458995
    [Abstract] [Full Text] [Related]

  • 11. Progressive supranuclear palsy: MRI and pathological findings.
    Yagishita A, Oda M.
    Neuroradiology; 1996 May; 38 Suppl 1():S60-6. PubMed ID: 8811682
    [Abstract] [Full Text] [Related]

  • 12. Study of the rostral midbrain atrophy in progressive supranuclear palsy.
    Kato N, Arai K, Hattori T.
    J Neurol Sci; 2003 Jun 15; 210(1-2):57-60. PubMed ID: 12736089
    [Abstract] [Full Text] [Related]

  • 13. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Salvatore C, Cerasa A, Castiglioni I, Gallivanone F, Augimeri A, Lopez M, Arabia G, Morelli M, Gilardi MC, Quattrone A.
    J Neurosci Methods; 2014 Jan 30; 222():230-7. PubMed ID: 24286700
    [Abstract] [Full Text] [Related]

  • 14. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
    Quattrone A, Nicoletti G, Messina D, Fera F, Condino F, Pugliese P, Lanza P, Barone P, Morgante L, Zappia M, Aguglia U, Gallo O.
    Radiology; 2008 Jan 30; 246(1):214-21. PubMed ID: 17991785
    [Abstract] [Full Text] [Related]

  • 15. The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy.
    Massey LA, Jäger HR, Paviour DC, O'Sullivan SS, Ling H, Williams DR, Kallis C, Holton J, Revesz T, Burn DJ, Yousry T, Lees AJ, Fox NC, Micallef C.
    Neurology; 2013 May 14; 80(20):1856-61. PubMed ID: 23616165
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy.
    Hussl A, Mahlknecht P, Scherfler C, Esterhammer R, Schocke M, Poewe W, Seppi K.
    Mov Disord; 2010 Oct 30; 25(14):2444-9. PubMed ID: 20878992
    [Abstract] [Full Text] [Related]

  • 17. MR vs CT in progressive supranuclear palsy.
    Masucci EF, Borts FT, Perl SM, Wener L, Schwankhaus J, Kurtzke JF.
    Comput Med Imaging Graph; 1995 Oct 30; 19(4):361-8. PubMed ID: 8653674
    [Abstract] [Full Text] [Related]

  • 18. Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging.
    Tsukamoto K, Matsusue E, Kanasaki Y, Kakite S, Fujii S, Kaminou T, Ogawa T.
    Neuroradiology; 2012 Sep 30; 54(9):947-55. PubMed ID: 22274571
    [Abstract] [Full Text] [Related]

  • 19. Phonemic Verbal Fluency and Midbrain Atrophy in Progressive Supranuclear Palsy.
    Luca A, Nicoletti A, Donzuso G, Terravecchia C, Cicero CE, D'Agate C, Rascuná C, Manna R, Mostile G, Zappia M.
    J Alzheimers Dis; 2021 Sep 30; 80(4):1669-1674. PubMed ID: 33720901
    [Abstract] [Full Text] [Related]

  • 20. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
    Longoni G, Agosta F, Kostić VS, Stojković T, Pagani E, Stošić-Opinćal T, Filippi M.
    Mov Disord; 2011 Feb 01; 26(2):247-55. PubMed ID: 21412831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.